Blogs
When a sponsor’s biologic program expanded from a domestic Phase 1 design into a multi-region trial spanning New Zealand, EMEA, and APAC, the bioanalytical challenge centered on keeping a fragile, time-sensitive sample chain intact across nine additional clinical sites, two outsourced processing labs, and a central analytical lab, all…
This symposium is for the drug development professional who wants to know more about how therapies of a variety of modalities move from preclinical through to clinical proof of concept. The preclinical data required and nice to have for optimal development as well as clinical design, planning and execution…